Jack Pengfei Tang

5PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Evolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 13, 2024
Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis.

Jack Pengfei Tang, Penelope Lafeuille, Alexandru Socolov

|Sep 28, 2023
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.

Kyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham

|Oct 19, 2022
Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy.

Jack Pengfei Tang, Cole W Peters, Crystal Quiros

|Feb 05, 2021
CARD8 is an inflammasome sensor for HIV-1 protease activity.

Qiankun Wang, Hongbo Gao, Kolin M Clark

|Feb 09, 2018
An alternatively spliced form affecting the Marked Box domain of Drosophila E2F1 is required for proper cell cycle regulation.

Minhee Kim, Jack P Tang, Nam-Sung Moon

Pageof 1

Frequent Collaborators

2 joint publications

Theodore S Nowicki

2 joint publications

Theodore B Moore

1 joint publications

Minhee Kim

1 joint publications

Nam-Sung Moon